| Name | Title | Contact Details |
|---|
We are the Southwest`s leading provider of comprehensive home healthcare products and services. We are committed to full-service homecare solutions that give our patients mobility and independence. Preferred Homecare/Lifecare Solutions has nearly 2,000 employees in over 60 locations, 7 Pharmacies, and 5 Ambulatory Infusion Suites, across the Western United States, all committed to offer the best care possible. We offer a full range of respiratory, home infusion and home medical equipment therapies and services. We are accredited by the Accreditation Commission for Health Care (ACHC). Meeting or exceeding each and every one of ACHC`s standards demonstrates our commitment to delivering the highest quality products and services to our patients. Our patient services teams include more than 750 highly skilled clinicians, (pharmacists, nurses, respiratory therapists, dietitians, and pharmacy techs) patient service technicians and customer service representatives all focused on providing unparalleled support, education, and prompt and courteous service. Your satisfaction with your care is our top priority. Our comprehensive line of products and services include: • Infusion Therapy • Specialty Pharmacy • Nutritional Products and Services, including enteral and parenteral • Respiratory Therapy • Oxygen Therapy • Sleep Apnea Products • Home Medical Equipment • Medical Supplies
Integra Radionics is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EBT Medical was founded in 2014 with a mission to develop novel neuromodulation technologies which restore control, dignity and independence to those silently suffering from pelvic floor disorders.
Companion Medical is a leader in the development of advanced technology to improve diabetes care. Companion`s InPen system is available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.